Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
We focus on a science-backed, empathetic approach that recognizes every individuals body reacts differently to treatment
Patients with Cardiovascular Risk Factors: Research suggests that GLP1 receptor agonists may provide cardiovascular benefits, including reduced risk of heart attack and stroke in patients with type 2 diabetes
With continued medication use, spontaneous resolution has been documented at four to six weeks and up to four months
The average body mass index when they enrolled in the study was 37 kg/m 2 , which is considered obesity
Meals are portion-controlled with higher protein content, and Factor includes a free 20-minute dietitian coaching session
US$ 23.45
US$ 25.51
US$ 27.41
US$ 26.35
